Risk inventory important for conduct of clinical research

Yesterday, the cabinet declared a lockdown to reduce the spread of the coronavirus. In response to this, CCMO would like to draw the attention of sponsors and investigators once again to the importance of a risk inventory for the conduct of clinical research.

The risk inventory is part of the requirements for the (re)start of clinical research, as published in this document of the Health and Youth Care Inspectorate.

More information regarding the coronavirus outbreak can be found on our theme page.